ALK-Abelló A/S (OTC:AKBLF – Get Free Report)’s share price traded down 0.8% during mid-day trading on Monday . The stock traded as low as $35.80 and last traded at $35.80. 270 shares traded hands during mid-day trading, a decline of 1% from the average session volume of 274 shares. The stock had previously closed at $36.10.
ALK-Abelló A/S Stock Performance
The firm’s 50 day moving average is $35.79 and its 200 day moving average is $32.13.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Featured Stories
- Five stocks we like better than ALK-Abelló A/S
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
